Kopran Limited (BOM:524280)

Market Cap	8.80B
Revenue (ttm)	6.25B
Net Income (ttm)	349.06M
Shares Out	48.29M
EPS (ttm)	7.23
PE Ratio	25.21
Forward PE	n/a
Dividend	3.00 (1.63%)
Ex-Dividend Date	Sep 4, 2025

Volume	21,650
Average Volume	25,124
Open	185.65
Previous Close	184.55
Day's Range	181.05 - 186.25
52-Week Range	154.05 - 365.30
Beta	0.28
RSI	66.84
Earnings Date	Aug 8, 2025

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, s...

• Industry: Pharmaceutical Preparations
• Founded: 1958
• Employees: 1,024
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524280

Financial Performance

In 2024, Kopran's revenue was 6.30 billion, an increase of 2.44% compared to the previous year's 6.15 billion. Earnings were 385.52 million, a decrease of -24.34%.